Compound 65 was shown to induce autophagy in tumor cells via the BRD4-AMPK-mTOR-ULK pathway and exhibits a striking anti-tumor activity in breast cancer xenograft models and zebrafish in vivo. The gene discussed is MTOR; the disease is neoplasm.